eletriptan has been researched along with Recrudescence in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulsattar, Y; Almas, M; Bhambri, R; Chatterjee, A; Martin, VT; Ramos, E; Silberstein, S | 1 |
| Bernstein, CD; Marcus, DA; Rudy, TE; Sullivan, EA | 1 |
| Cheong, YM; Chia, YC; Denaro, J; Hettiarachchi, J; Lim, SH; Wang, SJ | 1 |
| Healey, PJ; Mullins, CD; Perfetto, EM; Subedi, PR; Weis, KA | 1 |
| Deleu, D; Hanssens, Y | 1 |
| Ferrari, MD; Goadsby, PJ; Jackson, NC; Olesen, J; Poole, PH; Senard, JM; Stovner, LJ | 1 |
| Ferrari, MD; Goadsby, PJ; Lipton, RB; Roon, KI | 1 |
3 review(s) available for eletriptan and Recrudescence
| Article | Year |
|---|---|
Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
Topics: Adult; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Female; Humans; Logistic Models; Menstruation; Middle Aged; Migraine Disorders; Outcome Assessment, Health Care; Pyrrolidines; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines | 2014 |
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Design; Drug Interactions; Humans; Inactivation, Metabolic; Indoles; Meninges; Migraine Disorders; Molecular Structure; Nociceptors; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Pyrrolidines; Randomized Controlled Trials as Topic; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recurrence; Serotonin Receptor Agonists; Structure-Activity Relationship; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents | 1999 |
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
Topics: Acute Disease; Administration, Oral; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Triazoles; Tryptamines | 2001 |
4 trial(s) available for eletriptan and Recrudescence
| Article | Year |
|---|---|
Perimenstrual eletriptan prevents menstrual migraine: an open-label study.
Topics: Administration, Oral; Adolescent; Adult; Comorbidity; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Medical Records; Menstruation Disturbances; Middle Aged; Migraine Disorders; Pain Measurement; Premenstrual Syndrome; Prospective Studies; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Tryptamines; Young Adult | 2010 |
Efficacy and safety of eletriptan 20 mg, 40 mg and 80 mg in Japanese migraineurs.
Topics: Administration, Oral; Adolescent; Adult; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Japan; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Prospective Studies; Pyrrolidines; Recurrence; Saliva; Treatment Outcome; Tryptamines | 2002 |
Efficacy of eletriptan in migraineurs with persistent poor response to nonsteroidal anti-inflammatory drugs.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2003 |
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Topics: Acute Disease; Administration, Oral; Adult; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Placebos; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines; Vasoconstrictor Agents | 2000 |
2 other study(ies) available for eletriptan and Recrudescence
| Article | Year |
|---|---|
[Strong and sustained-acting triptan. Therewith migraine does not return soon].
Topics: Administration, Oral; Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Placebos; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Tryptamines; Vasoconstrictor Agents | 2003 |
Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat.
Topics: Algorithms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Humans; Managed Care Programs; Migraine Disorders; Piperidines; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2005 |